Cargando…
mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
Chemotherapy can eradicate a majority of cancer cells. However, a small population of tumor cells often survives drug treatments through genetic and/or non-genetic mechanisms, leading to tumor recurrence. Here we report a reversible chemoresistance phenotype regulated by the mTOR pathway. Through a...
Autores principales: | Liu, Yuanhui, Azizian, Nancy G., Sullivan, Delaney K., Li, Yulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671908/ https://www.ncbi.nlm.nih.gov/pubmed/36396656 http://dx.doi.org/10.1038/s41467-022-34890-6 |
Ejemplares similares
-
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells
por: Du, Rong, et al.
Publicado: (2021) -
PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016) -
AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
por: Umanah, George K. E., et al.
Publicado: (2022) -
Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
por: Westhoff, Mike-Andrew, et al.
Publicado: (2013) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)